Dr. Michele Yang, MD
Child Neurology (Neurology with Special Qualifications in Child Neurology Physician)
13123 E 16th Ave
Aurora, CO 80045
Who else practices at this address →
Adams County includes primary care (2% of residents) shortage areas. About shortage areas
At a glance
- Medical school
- University of Pittsburgh School of Medicine (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2007
Licensed in Colorado since 2009, according to the Colorado Department of Regulatory Agencies. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: University of Pittsburgh School of Medicine
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neurology with Special Qualifications in Child Neurology Physician primary
CO license 48195 (first issued 2009; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- University Physicians Incorporated (3,215 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Payments from drug and device companies
In 2025, 4 companies reported 19 payments worth $13,762 in total to this clinician.
| Sarepta Therapeutics, Inc. | $9,289 |
|---|---|
| Ptc Therapeutics, Inc. | $4,376 |
| Novartis Pharmaceuticals Corporation | $60.00 |
| Astellas Pharma US Inc | $37.22 |
| Consulting Fee | $12,115 |
|---|---|
| Travel and Lodging | $1,117 |
| Food and Beverage | $469 |
| Compensation for services other than consulting (speaking, faculty) | $60.00 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sarepta Therapeutics, Inc. Jul 9, 2025 | Consulting Fee Elevidys · Genetic Disease | $9,115 |
| Ptc Therapeutics, Inc. Apr 10, 2025 | Consulting Fee | $3,000 |
| Ptc Therapeutics, Inc. Mar 30, 2025 | Travel and Lodging travel to LAS VEGAS, NV · in-kind | $596 |
| Ptc Therapeutics, Inc. Mar 30, 2025 | Travel and Lodging travel to LAS VEGAS, NV · in-kind | $401 |
| Ptc Therapeutics, Inc. Mar 30, 2025 | Travel and Lodging travel to LAS VEGAS, NV · in-kind | $78.00 |
| Novartis Pharmaceuticals Corporation Nov 12, 2025 | Compensation for services other than consulting (speaking, faculty) ZOLGENSMA · Neurology | $60.00 |
| Ptc Therapeutics, Inc. Mar 29, 2025 | Travel and Lodging travel to LAS VEGAS, NV · in-kind | $33.71 |
| Sarepta Therapeutics, Inc. Jul 9, 2025 | Travel and Lodging Elevidys · Genetic Disease · travel to Denver, CO · in-kind | $8.64 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 5 industry-funded studies in 2025, from 3 companies. The companies reported $266,212 in research payments for these studies, mostly to the institutions running them.
- NS-089/NCNP-02-201 in Boys With Duchenne Muscular Dystrophy (DMD)
Ns Pharma, Inc. - A Study of Nipocalimab in Children Aged 2 to Less Than 18 Years With Generalized Myasthenia Gravis
Janssen Research & Development, LLC - NS-050/NCNP-03 in Boys With DMD
Ns Pharma, Inc. - SRP-9001-401
Sarepta Therapeutics, Inc. - EDNHS
Sarepta Therapeutics, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.